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Hypertrophy of Ligamentum 
Flavum in Lumbar Spinal 
Stenosis Associated 
with Increased Proteinase 
Inhibitor Concentration
BY JONG-BEOM PARK, MD, PHD, JIN-KYUNG LEE, MD, PHD, SUNG-JIN PARK, MD, AND K. DANIEL RIEW, MD
Investigation performed at the Catholic University of Korea School of Medicine, Seoul, Republic of Korea
Background: It is well known that age-related fibrosis, or decreases in the elastin-to-collagen ratio of the ligamentum
flavum, along with hypertrophy of the ligamentum flavum, are associated with lumbar spinal stenosis. However, the
molecular mechanism by which this fibrosis and hypertrophy develop is unknown. Tissue inhibitors of matrix metallo-
proteinase (TIMPs) are proteinase inhibitors that suppress extracellular matrix degradation. Elevated TIMP-1 and
TIMP-2 expression has been implicated in various fibrotic diseases of the liver, kidney, lung, and heart. These TIMPs
can also induce cellular proliferation and inhibit apoptosis in a wide range of cell types. These findings led us to pos-
tulate that TIMP-1 and TIMP-2 might also be associated with hypertrophy and fibrosis of the ligamentum flavum in
lumbar spinal stenosis.
Methods: We quantified and localized TIMP expression in ligamentum flavum tissues that had been obtained during
surgery from thirty patients with spinal stenosis and from thirty gender-matched control patients with disc herniation.
The thickness of the ligamentum flavum at the level of the facet joint was measured on axial T1-weighted magnetic
resonance images. In addition, we examined ligamentum flavum tissues for the expression of markers of cellular pro-
liferation and apoptosis.
Results: The ligamentum flavum was significantly thicker in the patients with spinal stenosis (mean, 5.68 mm) than
in the patients with disc herniation (mean, 2.70 mm) (p < 0.001). The concentration of TIMP-2 in the ligamentum fla-
vum was significantly higher in the patients with spinal stenosis (mean, 12.62 ng/mL) than in those with disc hernia-
tion (mean, 8.85 ng/mL) (p = 0.028). TIMP-1 and TIMP-2 were detected in the cytoplasm of ligamentum flavum
fibroblasts. TIMP-1 and TIMP-2 concentrations were associated with hypertrophy of the ligamentum flavum (p = 0.015
and p = 0.003, respectively). None of the samples from the patients with stenosis had evidence of proliferation of lig-
amentum flavum fibroblasts. The expression of markers for apoptosis was significantly higher in the patients with spi-
nal stenosis (58.8%) than in those with disc herniation (26.6%) (p < 0.001).
Conclusions: Increased TIMP expression has been implicated in fibrosis and hypertrophy of the extracellular matrix
of several organs. Our results suggest that increased expression of TIMP-2 in ligamentum flavum fibroblasts is asso-
ciated with fibrosis and hypertrophy of the ligamentum flavum in patients with spinal stenosis.
Clinical Relevance: Gaining insights into the molecular pathogenesis of hypertrophy and fibrosis of the ligamentum
flavum may eventually result in new therapeutic and potentially noninvasive alternatives to the treatment of spinal
stenosis.
he ligamentum flavum is composed of elastin and col-
lagen fibers in a 2:1 ratio. The elastin fibers impart a yel-
low color to the structure and provide the elasticity, while
the collagen provides the stiffness and stability. With age, the
elastin-to-collagen ratio decreases, resulting in decreased elastic-
ity and increased stiffness or fibrosis. In addition, the ligamen-
tum flavum hypertrophies, and the combination sometimes
results in lumbar spinal stenosis1-5. Although the hypertrophy
and fibrosis have been postulated to be due to degenerative
changes secondary to the aging process and mechanical stress sec-
T
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ondary to instability, the pathogenesis remains undetermined.
Matrix metalloproteinases (MMPs) are a family of more
than twenty enzymes that digest proteins in the extracellular
matrix6-9. There are also inhibitors of MMPs, called tissue in-
hibitors of matrix metalloproteinase (TIMPs), and it is be-
lieved that, together, MMPS and TIMPs regulate the integrity
and homeostasis of the extracellular matrix. There are four
known TIMPs (TIMP-1 through 4) that suppress extracellu-
lar matrix degradation by forming an inhibitory 1:1 complex
with the MMPs10-18. Elevated expressions of TIMP-1 and
TIMP-2 have been implicated in the increased fibrosis found
in a wide variety of human organs, including the liver, kidney,
lung, and heart. TIMPs are also known to increase cellular
proliferation19-21 and inhibit programmed cell death (apopto-
sis) in a wide range of cell types22-26.
On the basis of what is known about TIMPs, we hypoth-
esized that they might also play a role in the hypertrophy of
the ligamentum flavum seen in lumbar spinal stenosis. We
postulated that TIMPs might alter the ligamentum flavum in
three ways: by increasing the density of the extracellular ma-
trix and promoting fibrosis by inhibiting MMPs, by increasing
fibroblast proliferation, and by reducing the rate of fibroblast
apoptosis. In the present study, our goals were to determine
(1) whether there is an increased concentration of TIMPs in
the ligamentum flavum of patients with spinal stenosis com-
pared with that in patients with disc herniation, and (2)
whether the ligamentum flavum in spinal stenosis has in-
creased fibroblast proliferation and/or decreased apoptosis, ei-
ther of which would result in increased cellularity. To our
knowledge, no one has previously investigated the association
between hypertrophy of the ligamentum flavum and concen-
trations of TIMP-1 and TIMP-2.
Materials and Methods
hirty samples of ligamentum flavum tissue were obtained
from thirty patients who were undergoing decompression
because of neurogenic claudication due to lumbar spinal steno-
sis that had been unresponsive to conservative measures for at
least three months. None of these patients received epidural or
selective nerve-root blocks. Twenty-one patients were female,
and nine were male. The mean age of the patients at the time of
surgery was 63.7 years (range, fifty-two to seventy-eight years).
Patients with degenerative spondylolisthesis were excluded
from the study. Seventeen patients underwent a one-level oper-
ation; nine, a two-level operation; and four, a three-level opera-
tion. We tried to obtain the entire layer of the central portion of
the ligamentum flavum, and we removed the epidural fat from
the ligamentum flavum tissues. Half of each ligamentum fla-
vum specimen was fixed in 4% neutral formalin, decalcified
with 20% EDTA for six weeks, and embedded in paraffin;
the other half was kept in a freezer at −70°C for subsequent
enzyme-linked immunosorbent assay (ELISA).
We randomly selected thirty gender-matched control pa-
tients with lumbar disc herniation from a group of 124 patients
who were being operatively managed for that disorder. The
mean age of the control patients was 31.7 years (range, nineteen
to forty-three years), which was significantly younger than the
mean age of the patients with spinal stenosis (p < 0.001).
Measurement of the Thickness 
of the Ligamentum Flavum
An axial T1-weighted magnetic resonance image (repetition
time, 600 msec; echo time, 30 msec) was made, with a 1.5-T
unit (Somatom Plus; Siemens, Erlangen, Germany), at the facet
joint level of the lesion for each patient. The maximum thick-
ness of the ligamentum flavum was traced with use of the man-
ual cursor technique and was computed automatically by the
installed software in the magnetic resonance imaging scanner.
All of the radiographic analyses were independently performed
by two experienced spine surgeons who were not involved in
the care of the patients. Each observer independently measured
the thickness of the ligamentum flavum twice, and the average
of the four measurements was used as the final thickness.
Quantification of TIMP-1 and 
TIMP-2 Concentrations by ELISA
After thawing, 100 mg of the ligamentum flavum tissue was ho-
mogenized with phosphate-buffered saline solution at 3000 rpm
in a tissue homogenizer (model 985-370, Tissue-Tearor; Bio-
Spec Products, Racine, Wisconsin). Centrifugation to 15,000
rpm was then performed at 4°C for thirty minutes, and the su-
pernatant was obtained. Quantification of protein was per-
formed according to Bradford’s method27 with use of a protein
assay kit (catalogue number 500-0006; Bio-Rad Laboratories,
Hercules, California), and optical density was measured at 595
nm with a spectrophotometer (Ultrospec 3000; Pharmacia Bio-
tech, Cambridge, United Kingdom) and adjusted equally to lev-
els of 0.5 mg/mL (total protein concentration) for each sample.
TIMP-1 and TIMP-2 concentrations were measured
twice in each sample with use of an ELISA kit with antibodies
that recognize human TIMP-1 and TIMP-2 (R and D Systems,
Minneapolis, Minnesota); the kit was used according to the
manufacturer’s instructions. The average of the two measure-
ments was considered to be the final concentration. For cali-
bration, we used human recombinant TIMP-1 and TIMP-2
provided by the supplier to construct a standard curve and to
obtain absolute values.
Apoptosis: Analysis with In Situ 
Nick End-Labeling (TUNEL) Assay
In situ terminal deoxynucleotidyl transferase-mediated deox-
yuridine triphosphate nick end-labeling (TUNEL) reaction was
performed with use of a TACS 2 TdT DAB In Situ Apoptosis
Detection Kit (Trevigen, Gaithersburg, Maryland) according to
the manufacturer’s instructions. One section (4 µm thick) was
treated with proteinase K. Endogenous peroxidase was removed
with 2% H2O2. The 3′-OH ends of the fragmented DNA were
marked with TdT dNTP and divalent cation by adding TdT.
Two pathologists, who were unaware of the clinical data, were
responsible for counting total and TUNEL-positive ligamentum
flavum fibroblasts under ten randomly selected high-power
fields (×400). The apoptosis index was calculated as TUNEL-
T
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positive cells/total cells × 100%. Human tonsil tissue was used
as a positive control.
Cellular Proliferation: Analysis with 
Immunohistochemistry for TIMPs and Ki-67
Ki-67, a cellular proliferation marker, was assayed to determine
if there was evidence of proliferation of ligamentum flavum fi-
broblasts. Three consecutive 4-µm-thick sections were cut on a
microtome, deparaffinized in xylene, and rehydrated. To deter-
mine the expression of TIMP-1, TIMP-2, and Ki-67, the avi-
din-biotin-peroxidase complex method and a Histostain-plus
SP kit (Zymed Laboratories, South San Francisco, California)
Fig. 1-A
Immunohistochemical studies showing fibroblasts within the ligamentum flavum that are posi-
tively stained (arrows) for TIMP-1 (Fig. 1-A) and TIMP-2 (Fig. 1-B) (×400).
Fig. 1-B
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were used according to the manufacturer’s instructions. Puri-
fied mouse monoclonal antibodies to TIMP-1 and TIMP-2
(NeoMarkers, Fremont, California) and Ki-67 (DakoCytoma-
tion, Glostrup, Denmark) were used for this study at an opti-
mum dilution of 1:20, 1:50, and 1:75, respectively. A human
breast carcinoma and a human colon carcinoma were used as
positive controls for TIMP-1 and TIMP-2, and tonsil tissue was
used for Ki-67.
Statistical Analysis
The independent-sample t test was used to compare the patients
with lumbar spinal stenosis and those with disc herniation in
Fig. 2-A
TUNEL-positive fibroblasts (arrows) were identified in samples of ligamentum flavum from pa-
tients with spinal stenosis (×400). 
Fig. 2-B
Human tonsil tissue was used as a positive control.
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terms of the patients’ age, TIMP-1 and TIMP-2 concentrations,
ligamentum flavum thickness, and apoptosis index. The relation-
ship between the TIMP concentration and the thickness of the
ligamentum flavum was determined with the Pearson correlation
test. A p value of <0.05 was considered to be significant.
Results
Thickness of the Ligamentum Flavum
he mean thickness of the ligamentum flavum (and stan-
dard deviation) was 5.68 ± 1.02 mm (range, 4.5 to 7.2 mm)
in the patients with lumbar spinal stenosis and 2.70 ± 0.35 mm
T
Fig. 3-A
Immunohistochemical study showing that the fibroblasts within the ligamentum flavum are not 
stained with Ki-67 (×400).
Fig. 3-B
Human tonsil tissue was used as a positive control.
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(range, 2.2 to 3.3 mm) in those with lumbar disc herniation.
The difference was significant (p < 0.001) (Table I).
TIMP-1 and 2 Concentrations
With the number of samples available, there was no significant
difference in the mean concentration of TIMP-1 between the
patients with lumbar spinal stenosis (6.33 ± 2.81 ng/mL) and
those with lumbar disc herniation (4.55 ± 2.06 ng/mL) (p =
0.08) (Table I). In contrast, the difference between the mean
concentration of TIMP-2 in the patients with lumbar spinal
stenosis (12.62 ± 3.47 ng/mL; range, 6.9 to 19.1 ng/mL) and
that in the patients with disc herniation (8.85 ± 4.33 ng/mL;
range, 4.3 to 12.6 ng/mL) was significant (p = 0.028) (Table I).
Fibroblasts in the ligamentum flavum of both groups of pa-
tients showed positive cytoplasmic staining for TIMP-1 and
TIMP-2 (Figs. 1-A and 1-B).
Correlation Between TIMP Concentration 
and Ligamentum Thickness
The Pearson correlation test showed a positive correlation be-
tween the TIMP-2 concentration and the thickness of the liga-
mentum flavum (correlation coefficient = 0.631, p = 0.003) and
between the TIMP-1 concentration and the thickness of the lig-
amentum flavum (correlation coefficient = 0.534, p = 0.015).
Apoptosis of Ligamentum Flavum Cells
There was a mean of 35.7 ± 18.4 total ligamentum flavum fi-
broblasts and 21.0 ± 10.7 TUNEL-positive ligamentum fla-
vum fibroblasts per ten high-power fields (×400) in the
specimens from the patients with spinal stenosis; the apopto-
sis index was 58.8% ± 18.3% (Figs. 2-A and 2-B). The speci-
mens from the patients with disc herniation showed a mean of
53.1 ± 17.7 total and 14.1 ± 5.63 TUNEL-positive ligamentum
flavum fibroblasts per ten high-power fields, and the apopto-
sis index was 26.6% ± 21.3%. The apoptosis index was signifi-
cantly higher for the group with lumbar spinal stenosis than it
was for the group with disc herniation (p < 0.001), which dis-
proved our theory that ligamentum flavum hypertrophy was
due to a decrease in cell death.
Fibroblast Proliferation in the Ligamentum Flavum
None of the fibroblasts within the ligamentum flavum sam-
ples from the patients with spinal stenosis or from those with
disc herniation stained positively with Ki-67 (cellular prolifer-
ation marker), suggesting that fibroblasts were not proliferat-
ing in any of the samples (Figs. 3-A and 3-B).
Discussion
here are four types of tissue inhibitors of matrix metallo-
proteinase (TIMP-1 through 4). They bind strongly but
noncovalently to activated MMPs (matrix metalloproteinases),
enzymes that digest proteins in the extracellular matrix. TIMPs
are co-expressed with the MMPs and contribute to the regula-
tion of their local activity so that increases in TIMP levels re-
duce MMP activity. Decreased MMP activity impairs matrix
degradation, which has been demonstrated to be associated
with fibrotic diseases. As the activity of MMPs is regulated by
specific TIMPs, the imbalance between MMPs and TIMPs is
thought to be an important determinant of extracellular matrix
deposition and breakdown. TIMPs also have other important
biological functions, including promotion of cellular prolifera-
tion and inhibition of apoptosis (programmed cell death) in a
wide range of cell types.
On the basis of this information, we postulated that
TIMPs may also play a role in the ligamentum flavum hypertro-
phy associated with lumbar stenosis, which is characterized by
increased extracellular matrix and fibrosis in the ligamentum.
We also hypothesized that TIMPs might influence ligamentum
hypertrophy by increasing proliferation and decreasing apopto-
sis of the ligamentum fibroblasts. To test our hypotheses, we
measured the concentrations of TIMP-1 and TIMP-2 in liga-
mentum flavum tissues from patients with lumbar spinal steno-
sis and compared them with those from a gender-matched
group of patients who had lumbar disc herniation.
We found that the TIMP-2 concentration was signifi-
cantly (1.43-fold) higher in the patients with spinal stenosis
than it was in those with disc herniation (p = 0.028), and a sig-
nificant association was observed between the TIMP-2 con-
centration and the thickness of the ligamentum flavum (p =
0.003). The TIMP-1 concentration in the patients with spinal
stenosis was also positively associated with the thickness of the
ligamentum flavum (p = 0.015). In addition, TIMP-1 and 2
were positively stained in the cytoplasm of ligamentum fla-
vum fibroblasts. These results suggest that increased expres-
sion of TIMPs, especially TIMP-2, in ligamentum flavum
fibroblasts may be associated with hypertrophy of the liga-
mentum flavum in spinal stenosis.
We had theorized that TIMPs might play a role in steno-
T
TABLE I Comparison of the Thickness of Ligamentum Flavum and the Concentrations of TIMP-1 and TIMP-2 Between the 
Patients with Lumbar Spinal Stenosis and Those with Disc Herniation
Spinal 
Stenosis* (N = 30)
Lumbar Disc 
Herniation* (N = 30) P Value
Ligamentum flavum thickness 5.68 ± 1.02 mm 2.70 ± 0.35 mm <0.001†
Concentration of TIMP-1 6.33 ± 2.81 ng/mL 4.55 ± 2.06 ng/mL 0.081
Concentration of TIMP-2 12.62 ± 3.47 ng/mL 8.85 ± 4.33 ng/mL 0.028†
*The values are given as the mean and standard deviation. †The value was determined to be significant with the independent-sample t test.
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sis by decreasing the rate at which fibroblasts undergo pro-
grammed cell death, resulting in increased cellularity. We
found that the expression of intracellular TIMP-2 in the liga-
mentum flavum fibroblasts was higher in the patients with
spinal stenosis than in the patients with disc herniation. How-
ever, contrary to our hypothesis, the programmed death rate
of fibroblasts was significantly higher and the number of total
cells was lower in the patients with spinal stenosis than they
were in those with disc herniation. These findings suggest that
the ligamentum flavum hypertrophy in spinal stenosis is not
caused by an increase in cell number resulting from a delay in
cell death. Furthermore, these results suggest that TIMPs do
not have the biologic function of inhibiting apoptosis of liga-
mentum flavum fibroblasts.
We had also theorized that TIMPs might play a role in
ligamentum flavum hypertrophy not just by decreasing cell
death, but also by inducing fibroblastic cell proliferation. We
utilized the Ki-67 antigen, a nuclear protein, which is prefer-
entially expressed during all active phases of the cell cycles (G1,
S, G2, and M-phase) as well as mitosis but is absent in resting
cells (G0-phase). The antigen is rapidly degraded as the cell en-
ters the nonproliferative state. Therefore, the Ki-67 antigen is
accepted as an excellent marker for cellular proliferation.
Again, contrary to our hypothesis, the ligamentum flavum fi-
broblasts from the patients with spinal stenosis and those with
disc herniation tested negative for the Ki-67 antigen, suggest-
ing that they were not proliferating. These results suggest that
TIMPs do not have the biologic function of inducing prolifer-
ation of ligamentum flavum fibroblasts.
Few authors have investigated the biochemical etiology
of ligamentum flavum hypertrophy. We previously demon-
strated the expression of transforming growth factor-beta 1
(TGF-β1) in ligamentum flavum fibroblasts and found that
the concentration was significantly higher in patients with spi-
nal stenosis than it was in patients with disc herniation28. In an
in vitro study, Nakatani et al. found that mechanical stretching
force promotes collagen synthesis by cultured cells from hu-
man ligamentum flavum tissues through increased TGF-β1
production29. These studies support our finding that TGF-β1
can influence the expression of both MMPs and TIMPs30,31. To-
gether, these studies suggest that biochemical as well as me-
chanical factors should be considered as possible etiologies of
ligamentum flavum hypertrophy in lumbar spinal stenosis.
As with any investigation, our study had limitations. First,
the patients with spinal stenosis were significantly older than
those with disc herniation. Therefore, we cannot exclude the
possibility that the natural aging process had an impact on the
hypertrophy of the ligamentum flavum or on the other variables
that we measured in this study. In other words, some (perhaps
all) of the changes that were noted in our study could have sim-
ply been related to age. Second, it is not known whether the in-
creased concentration of TIMP-2 in the patients with spinal
stenosis was a local or systemic phenomenon. To address this is-
sue, we are currently in the process of comparing serum TIMP-1
and TIMP-2 concentrations in patients with lumbar spinal
stenosis with those concentrations in normal healthy volunteers.
In conclusion, the increased expression of TIMPs, espe-
cially TIMP-2, in ligamentum flavum fibroblasts might result
in fibrosis and hypertrophy of the ligamentum flavum in spi-
nal stenosis by inhibiting MMP activity, but not by causing
proliferation of ligamentum flavum fibroblasts or inhibiting
apoptosis of ligamentum flavum fibroblasts. Gaining insights
into the biochemical pathophysiology of ligamentum flavum
hypertrophy might elucidate novel noninvasive therapeutic
approaches to the treatment of spinal stenosis. 
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